STK11 and neoplasm: Inactivating aberrations in STK11 have been identified as critical drivers of an immunosuppressive tumor microenvironment in NSCLC, characterized by diminished infiltration of CD3+, CD4+, and CD8+ tumor-infiltrating lymphocytes and an accumulation of TANs [91].